Oligonucleotides are used in a variety of molecular biology techniques, from next-generation sequencing to genetic testing. Maintaining the sequence fidelity of synthetic oligonucleotides is critical to their use. Oligonucleotides are chemically synthesized using building blocks, protected phosphoramidites of natural or chemically modified nucleosides, or, to a lesser extent, non-nucleosidic compounds. Although oligonucleotide syntheses were performed earlier in solution, the solid-phase approach to these syntheses rapidly became the method of choice even for large-scale (5 to 15 mmol) preparations. Since oligonucleotides are usually assembled by step-wise coupling of individual monomer nucleosides, coupling yields per step must be as close to 100% as possible to obtain practical yields of full-length oligonucleotides.
Access Full Report @ https://www.databridgemarketresearch.com/reports/india-oligonucleotides-synthesis-market
Key Findings of the Study
Increasing Government Investments and R&D Expenditure
The benefits of Oligonucleotides Synthesis can lead to increased demand for various testing methods. The advantages of quick results, reduced turnaround times, and improved patient care, there is a greater likelihood of healthcare providers incorporating oligonucleotides synthesis into their practices. This increased demand can drive the growth of the oligonucleotides synthesis market. The government, federations, and major players in the market are involved in spreading awareness among society across developing countries. These initiatives by the players and government are helping the users to reach out and take advantage of the policies made for low-income and developing nations. The growth of oligonucleotides synthesis in pharmaceutical companies and forensic labs is already strongly encouraged by government initiatives and the prevalence of time-sensitive medical diseases.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Custom Oligos and Predesigned Oligos), Product Type (Equipment's, Reagents, and Consumables & Accessories), Synthesis Method (Solid Phase Oligo Synthesis Method and Liquid/Enzymatic Phase Oligo Synthesis Method), Application (Diagnostics, Therapeutics, Research, Agriculture, Food and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic Centers, Contract Research Organization, Research & Academic Institutes, and Forensic Labs), Distribution Channel (Direct Tender, Retail Sales and Others)
|
|
Country Covered
|
India
|
|
Market Players Covered
|
Thermo Fisher Scientific Inc (U.S.), Agilent Technologies Inc (U.S.), Merck KGaA (Germany), Danaher, (U.S.) LGC Limited (U.K.), Eurofins Genomics (India), GENERAL ELECTRIC (U.S.), METTLER TOLEDO (India), TriLink BioTechnologies (U.S.), Ajinomoto Bio-Pharma (Japan) among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The India oligonucleotides synthesis market is segmented into six notable segments such as type, product type, synthesis method, application, end user, and distribution channel.
- On the basis of type, the India oligonucleotides synthesis market is segmented into custom oligos and predesigned oligos.
In 2023, the custom oligos segment is expected to dominate the India oligonucleotides synthesis market
In 2023, the custom oligos segment is expected to dominate the market with a 58.44% market share due to rising technological advancements.
- On the basis of product type, the market is segmented equipment's and reagents, consumables & accessories. In 2023, the equipment's segment is expected to dominate the market with a 52.47% market share.
- On the basis of synthesis method, the market is segmented into solid phase oligo synthesis method and liquid/enzymatic phase oligo synthesis method. In 2023, the solid phase oligo synthesis method segment is expected to dominate the market with a 52.17% market share.
- On the basis of application, the India oligonucleotides synthesis market is segmented into diagnostics, therapeutics, research, agriculture, food, and others.
In 2023, the diagnostics segment is expected to dominate the India oligonucleotides synthesis market
In 2023, the diagnostics segment is expected to dominate the India oligonucleotides synthesis market with a 34.26% market share as they are effectively used to diagnose certain infectious diseases.
- On the basis of end user, the market is segmented into pharmaceutical and biotechnology companies, diagnostic centers, contract research organization, research & academic institutes, forensic labs. In 2023, the pharmaceutical and biotechnology companies segment is expected to dominate the market with a 30.98% market share.
- On the basis of distribution channel, the market is segmented into direct tender, retail sales and others. In 2023, the direct tender segment is expected to dominate the market with a 47.39% market share.
Major Players
Data Bridge Market Research recognizes the following companies as the market players in India oligonucleotides synthesis market are Thermo Fisher Scientific Inc (U.S.), Agilent Technologies Inc (U.S.), Merck KGaA (Germany), Danaher, (U.S.) LGC Limited (U.K.), Eurofins Genomics (India), GENERAL ELECTRIC (U.S.), METTLER TOLEDO (India), TriLink BioTechnologies (U.S.), Ajinomoto Bio-Pharma (Japan) among others.
Market Development
- In December 2022, Thermo Fisher Scientific, the world leader in serving science, announced the launch of the TrueMark Infectious Disease Research Panels designed to enable rapid and accurate detection and categorization for investigating microorganisms that cause respiratory, vaginal, urinary, gastrointestinal, and sexually transmitted diseases. TrueMark Infectious Disease Research Panels are analytically sensitive, syndromic panels for the analysis of a wide range of infectious disease pathogens. This will help the organization in developing overall revenue.
- In January 2021, Merck KGaA announced the acquisition of AmpTec, a leading Hamburg, Germany-based, mRNA contract development and manufacturing organization (CDMO). The deal strengthens Merck’s capabilities to develop and manufacture mRNA for its customers for use in vaccines, treatments, and diagnostics applications.
- In April 2019, Agilent Technologies, Inc. launched a new Mass Spectrometry solution Agilent 6546 LC/Q-TOF which is an advanced version of traditional spectroscopy. This will improve the analytical testing of food and also be used in metabolomics research with accurate result.
- In March 2018, DANAHER signed an agreement to acquire Integrated DNA Technologies (IDT) which is a provider of high-value consumables for genomics applications in molecular biology, qPCR synthetic biology, and molecular diagnostics. As a result, there will be an expansion in the genomic market which will increase its product portfolio and revenue.
- In April 2019, Agilent Technologies, Inc. launched a new Mass Spectrometry solution Agilent 6546 LC/Q-TOF which is the advanced version of traditional spectroscopy.
For more detailed information about the India oligonucleotides synthesis market report, click here – https://www.databridgemarketresearch.com/reports/india-oligonucleotides-synthesis-market
